Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan

Hofmann-Thiel S., van Ingen J., Feldmann K., Turaev L., Uzakova G. T., Murmusaeva G., van Soolingen D., Hoffmann H.

Source: Eur Respir J 2009; 33: 368-374
Journal Issue: February
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hofmann-Thiel S., van Ingen J., Feldmann K., Turaev L., Uzakova G. T., Murmusaeva G., van Soolingen D., Hoffmann H.. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur Respir J 2009; 33: 368-374

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Molecular fingerprinting of mycobacterium tuberculosis isolates in new cases of tuberculosis using mycobacterial interspersed repetitive unit–variable number tandem repeat genotyping (MIRU-VNTR) – Epidemiology of drug resistant tuberculosis in Greece
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Genetic diversity of multidrug resistant mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran, using MIRU-VNTR technique
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016

Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

MIC and gyrA/B genetic analyses of fluoroquinolones against mycobacterium tuberculosis isolated in Japan
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016


Detection of M. tuberculosis multi-drug resistance using GenoType® MTBDRplus
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Molecular characterization of mycobacterium tuberculosis resistant to fluoroquinolones, distributed in Saratov region
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



GenoType MTBDRsl performance on clinical samples with diverse genetic background},
Source: Eur Respir J 2012; 40: 690-698
Year: 2012



High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

XDR and MDR-TB genetic markers of M. tuberculosis strains circulating in Kyrgyz Republic
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011


Genetic polymorphism and phenotypic resistance of Mycobacterium tuberculosis to fluoroquinolones of different generations
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Rapid genotypic assays for detection the rifampin and isoniazid resistance in M. tuberculosis strains and clinical specimens in Moldova
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010

Detection of mutations associated with isoniazid and rifampicin resistance in M. tuberculosis isolates from Kazakhstan
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010

Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011


IS6110-PCR typing of isolates of M. tuberculosis from Novosibirsk, Russia
Source: Eur Respir J 2002; 20: Suppl. 38, 22s
Year: 2002

Typing of Mycobacterium avium by various number tandem repeats (VNTR) analysis
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006


Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017